Pristimerin Suppresses RANKL-Induced Osteoclastogenesis and Ameliorates Ovariectomy-Induced Bone Loss

• Main Authors: Dahu Qi (Author), Hui Liu (Author), Xuying Sun (Author), Danni Luo (Author), Meipeng Zhu (Author), Tenghui Tao (Author), Chenghao Gao (Author), Chuankun Zhou (Author), Wei Zhou (Author), Jun Xiao (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Osteoporosis is characterized by bone loss and destruction of trabecular architecture, which greatly increases the burden on the healthcare system. Excessive activation of osteoclasts is an important cause of osteoporosis, and suppression of osteoclastogenesis is helpful for the treatment of osteopo...